相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Limb-Girdle Muscular Dystrophy Type 2D Gene Therapy Restores α-Sarcoglycan and Associated Proteins
Jerry R. Mendell et al.
ANNALS OF NEUROLOGY (2009)
INHIBITION OF MYOSTATIN WITH EMPHASIS ON FOLLISTATIN AS A THERAPY FOR MUSCLE DISEASE
Louise R. Rodino-Klapac et al.
MUSCLE & NERVE (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy
Kathryn R. Wagner et al.
ANNALS OF NEUROLOGY (2008)
Use of doping agents, particularly anabolic steroids, in sports and society
Folke Sjoqvist et al.
LANCET (2008)
Facioscapulohumeral muscular dystrophy
Rabi Tawil
NEUROTHERAPEUTICS (2008)
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors
Amanda M. Haidet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Quadrupling Muscle Mass in Mice by Targeting TGF-β Signaling Pathways
Se-Jin Lee
PLOS ONE (2007)
Lack of myostatin results in excessive muscle growth but impaired force generation
Helge Amthor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Exploring the frontiers of therapeutic dxon skipping for Duchenne muscular dystrophy by double targeting within one or multiple dxons
Annemieke Aartsma-Rus et al.
MOLECULAR THERAPY (2006)
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Paul Gregorevic et al.
NATURE MEDICINE (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Determination of specific CD4 and CD8 T cell epitopes after AAV2-and AAV8-hF.IX gene therapy
J Chen et al.
MOLECULAR THERAPY (2006)
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates
GP Gao et al.
MOLECULAR THERAPY (2006)
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of mouse AAV capsid-specific CD8+ T cell epitopes
DE Sabatino et al.
MOLECULAR THERAPY (2005)
Inclusion body myositis - Clinical features and clinical course of the disease in 64 patients
UA Badrising et al.
JOURNAL OF NEUROLOGY (2005)
Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery
S Abmayr et al.
MOLECULAR THERAPY (2005)
Practice parameter: Corticosteroid treatment of Duchenne dystrophy - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
RT Moxley et al.
NEUROLOGY (2005)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Regulation of muscle mass by myostatin
SJ Lee
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Differential distribution of follistatin isoforms: Application of a new FS315-specific immunoassay
AL Schneyer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis
A Rebbapragada et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer
M Cerletti et al.
GENE THERAPY (2003)
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression
B Langley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
KR Wagner et al.
ANNALS OF NEUROLOGY (2002)
Functional improvement of dystrophic muscle by myostatin blockade
S Bogdanovich et al.
NATURE (2002)
Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
SQ Harper et al.
NATURE MEDICINE (2002)
A prospective natural history study of inclusion body myositis: Implications for clinical trials
MR Rose et al.
NEUROLOGY (2001)
Regulation of myostatin activity and muscle growth
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Transcriptional control by the TGF-β/Smad signaling system
J Massagué et al.
EMBO JOURNAL (2000)